Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Assets Average (2016 - 2025)

Historic Assets Average for Sunshine Biopharma (SBFM) over the last 13 years, with Q3 2025 value amounting to $31.7 million.

  • Sunshine Biopharma's Assets Average rose 689.86% to $31.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year increase of 689.86%. This contributed to the annual value of $29.0 million for FY2024, which is 232.64% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Assets Average stood at $31.7 million, which was up 689.86% from $30.6 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Assets Average ranged from a high of $41.4 million in Q3 2022 and a low of $1.5 million during Q1 2021
  • Its 5-year average for Assets Average is $23.3 million, with a median of $28.1 million in 2023.
  • In the last 5 years, Sunshine Biopharma's Assets Average skyrocketed by 181839.86% in 2022 and then crashed by 3233.95% in 2023.
  • Quarter analysis of 5 years shows Sunshine Biopharma's Assets Average stood at $2.4 million in 2021, then skyrocketed by 1390.14% to $35.1 million in 2022, then dropped by 21.55% to $27.5 million in 2023, then increased by 10.22% to $30.3 million in 2024, then grew by 4.68% to $31.7 million in 2025.
  • Its Assets Average was $31.7 million in Q3 2025, compared to $30.6 million in Q2 2025 and $29.9 million in Q1 2025.